Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Phase II to Phase III fails without a program office already aware of the technology and with budget moving toward it
By delivering glutathione directly into the bloodstream, these treatments achieve higher concentrations of the antioxidant in the body much faster than oral supplements can
Hepatocytes can have as much as ten times the amount of reduced or active glutathione (GSH) than other cells
Xarelto (rivaroxaban) Disease area(s): Cardiovascular/hematology Manufacturer(s): Bayer/Johnson & Johnson 2024 Sales (USD): $6.14 billion Why it sold so well: In 2024, Bayers Xarelto experienced a significant 7% decline in global revenues of Imbruvica due to the expiration of its patent protection, leading to increased generic competition
Postmenopausal women also lost 23%
US$ 28.94
US$ 22.96
US$ 26.64
US$ 21.77
US$ 25.20
US$ 28.69
